Simplex Trading
NVCT icon

Simplex Trading’s Nuvectis Pharma NVCT Stock Holding History

Simplex Trading’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.4K Buy
1,600
+1,500
+1,500% +$16.8K ﹤0.01% 6771
2026
Q1 		$773 Sell
100
-50,400
-100% -$432K ﹤0.01% 8655
2025
Q4 		$381K Sell
50,500
-4,500
-8% -$29.3K ﹤0.01% 3577
2025
Q3 		$331K Buy
55,000
+47,200
+605% +$324K ﹤0.01% 4336
2025
Q2 		$58K Buy
7,800
+4,500
+136% +$40.8K ﹤0.01% 5776
2025
Q1 		$32K Buy
+3,300
New +$23.8K ﹤0.01% 6190

Other funds holding NVCT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Simplex Trading's NVCT Position: Q2 2026 in Review

Simplex Trading increased its Nuvectis Pharma (NVCT) stake by 1,109% in Q2 2026, buying an estimated $322K and bringing the position to 31,394 shares worth $577K. The position accounts for ﹤0.01% of the portfolio, ranked #3427.

Simplex Trading first reported a position in NVCT in Q2 2025 and has held it in 3 quarters since. 83 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • Simplex Trading held 31,394 shares of Nuvectis Pharma worth $577K as of Q2 2026.
  • Simplex Trading bought 28,798 Nuvectis Pharma shares in Q2 2026, an estimated $322K.
  • Nuvectis Pharma made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #3427 holding.
  • Simplex Trading first reported a position in Nuvectis Pharma in Q2 2025 and has held it in 3 quarters since.
  • 83 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.